33. Translational Biosciences. allogeneic umbilical cord mesenchymal stem
cell therapy for autism. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National
Library of Medicine (US). 2000- [cited 2016 July]. Available from:
https://clinicaltrials.gov/ct2/show/NCT02192749
NLM
Identifier:
NCT02192749.
34. Sutter Health; Michael Chez, MD. Autologous cord blood stem cells for
autism. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of
Medicine
(US).
2000-
[cited
2016
July].
Available
from:
https://clinicaltrials.gov/ct2/show/NCT01638819
NLM
Identifier:
NCT01638819.
35. NeuroGen Brain and Spine Institute. Stem Cell Therapy in Autism
Spectrum Disorders. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National
Library of Medicine (US). 2000- [cited 2016 July]. Available
from:https://clinicaltrials.gov/ct2/show/NCT01974973
NLM
Identifier:
NCT01974973.
36. Ageless Regenerative Institute. Adipose Derived Stem Cell Therapy for
Autism. In: ClinicalTrials. gov [Internet]. Bethesda (MD): National Library of
Medicine
(US).
2000-
[cited
2016
July].
Available
from:https://clinicaltrials.gov/ct2/show/NCT01502488
NLM
Identifier:
NCT01502488
Tài liệu tham khảo bổ sung
Germain B, Eppinger MA, Mostofsky SH, DiCicco-Bloom E, Maria BL.
Recent advances in understanding and managing autism spectrum disorders. J
Child Neurol. 2015; 30(14): p. 1887-920. doi: 10.1177/0883073815601499.
Nikolov RN, Bearss KE, Lettinga J, et al. Gastrointestinal symptoms in a
sample of children with pervasive developmental disorders. J Autism Dev
Disord. 2009; 39(3): 405-13. doi: 10.1007/s10803-008-0637-8.
Sheikh AM, Nagai A, Wakabayashi K, et al. Mesenchymal stem cell
transplantation modulates neuroinflammation in focal cerebral ischemia:
contribution of fractalkine and IL-5. Neurobiol Dis. 2011; 41(3): 717-24. doi:
10.1016/j.nbd.2010.12.009.
